C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/50 (2006.01) A61K 38/18 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C12N 15/62 (2006.01)
Patent
CA 2565300
The invention provides specific FGF-21 compounds fused to specific IgG4-Fc or HSA derivatives resulting in fusion proteins that are biologically active with an extended elimination half-life and a slower clearance. These FGF-21 compound fusion proteins and compositions are useful in treating type 2 diabetes, obesity, and metabolic syndrome.
L'invention fournit des composés spécifiques FGF-21 fusionnés aux dérivés spécifiques IgG4-Fc ou HSA résultant dans des protéines de fusion qui sont biologiquement actives avec une demi-vie et une clairance plus lente. Ces protéines de fusion de composés et de compositions sont utiles dans le traitement du diabète de type 2, de l'obésité et du syndrome métabolique
Glaesner Wolfgang
Millican Rohn Lee Junior
Tian Yu
Tschang Sheng-Hung Rainbow
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Fgf-21 fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fgf-21 fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fgf-21 fusion proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1684526